Home / Stocks / GEHC

GE HealthCare Technologies (GEHC, Health Care Equipment) Stock Valuation & Fair Value Favorable on our tests

GE HealthCare Technologies (GEHC, Health Care Equipment) trades at a blended P/E of 13.3, about 21% below its historical normal valuation, with a forward growth estimate of 10.4% and a PEG of 1.28. Analysts' one-year estimates have been hit 67% of the time. Priced at its historical normal P/E of 16.9 on the same blended earnings, the 2026-10-02 close of $64.29 corresponds to about $81.80 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-10-05
Blended P/E
13.3
Normal P/E
16.9
PEG
1.28
Fwd growth
10.4%
Div yield
0.2%
RSI (14)
39.5
Neutral
Technical context
  • Price $64.22 at the 2026-10-08 close, 1.3% below the 20-day average ($65.04) and 6.6% below the 50-day ($68.75).
  • RSI (14) at 39.5.
  • 52-week range $59.45 to $88.03: the price is 27.0% below the high and 8.0% above the low.

The Street vs SeerForecast

Wall Street's mean price target for GEHC is $83.05 across 19 analysts, 29.3% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: favorable on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from mixed on our tests (2026-06-10) to favorable on our tests (2026-10-05).

Blended P/E and rating by weekBlended P/E moved from 13.7 to 13.3 between 2026-06-10 and 2026-10-02, against a normal P/E of 16.9, with 1 rating change over 36 recorded weeks.2026-06-10: P/E 13.7, Mixed on our tests, recalculated for the week of 2026-06-102026-06-12: P/E 13.7, Mixed on our tests, recalculated for the week of 2026-06-142026-06-16: P/E 13.7, Mixed on our tests, recalculated for the week of 2026-06-162026-06-18: P/E 13.7, Mixed on our tests, recalculated for the week of 2026-06-212026-07-02: P/E 13.7, Mixed on our tests, recalculated for the week of 2026-07-022026-07-06: P/E 13.8, Mixed on our tests, recalculated for the week of 2026-07-062026-07-09: P/E 13.8, Mixed on our tests, recalculated for the week of 2026-07-092026-07-10: P/E 13.6, Mixed on our tests, recalculated for the week of 2026-07-122026-07-13: P/E 13.6, Mixed on our tests, recalculated for the week of 2026-07-132026-07-14: P/E 13.6, Mixed on our tests, recalculated for the week of 2026-07-142026-07-20: P/E 13.3, Mixed on our tests, recalculated for the week of 2026-07-202026-07-22: P/E 13.3, Mixed on our tests, recalculated for the week of 2026-07-222026-07-24: P/E 12.7, Mixed on our tests, recalculated for the week of 2026-07-252026-07-27: P/E 12.7, Mixed on our tests, recalculated for the week of 2026-07-272026-07-31: P/E 14.6, Mixed on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 14.2, Mixed on our tests, recorded live 2026-08-032026-08-07: P/E 14.7, Mixed on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 15.0, Mixed on our tests, recorded live 2026-08-102026-08-14: P/E 15.4, Mixed on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 15.4, Mixed on our tests, recorded live 2026-08-172026-08-21: P/E 15.4, Mixed on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 15.6, Mixed on our tests, recorded live 2026-08-242026-08-27: P/E 15.6, Mixed on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 15.1, Mixed on our tests, recalculated for the week of 2026-08-282026-08-28: P/E 14.9, Mixed on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 14.9, Mixed on our tests, recorded live 2026-08-312026-09-04: P/E 14.3, Mixed on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 14.3, Mixed on our tests, recorded live 2026-09-072026-09-11: P/E 13.2, Mixed on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 13.2, Mixed on our tests, recorded live 2026-09-142026-09-18: P/E 13.3, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 13.3, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 13.8, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 13.8, Mixed on our tests, recorded live 2026-09-282026-10-02: P/E 13.3, Favorable on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 13.3, Favorable on our tests, recorded live 2026-10-0514.016.0Jun 10Jul 8Aug 6Sep 4Oct 2Normal P/E 16.9
Favorable on our testsMixed on our tests

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-06-10P/E 13.7-19%Mixed on our tests (recalculated)
2026-07-25P/E 12.7-25%Mixed on our tests (recalculated)
2026-08-24P/E 15.6-8%Mixed on our tests
2026-10-03P/E 13.3-21%Favorable on our tests (recalculated)
2026-10-05P/E 13.3-21%Favorable on our tests ← now
Show all 36 weeks
WeekBlended P/EPremium to normal P/ERating
2026-06-10P/E 13.7-19%Mixed on our tests (recalculated)
2026-06-14P/E 13.7-19%Mixed on our tests (recalculated)
2026-06-16P/E 13.7-19%Mixed on our tests (recalculated)
2026-06-21P/E 13.7-19%Mixed on our tests (recalculated)
2026-07-02P/E 13.7-19%Mixed on our tests (recalculated)
2026-07-06P/E 13.8-18%Mixed on our tests (recalculated)
2026-07-09P/E 13.8-18%Mixed on our tests (recalculated)
2026-07-12P/E 13.6-19%Mixed on our tests (recalculated)
2026-07-13P/E 13.6-19%Mixed on our tests (recalculated)
2026-07-14P/E 13.6-19%Mixed on our tests (recalculated)
2026-07-20P/E 13.3-21%Mixed on our tests (recalculated)
2026-07-22P/E 13.3-21%Mixed on our tests (recalculated)
2026-07-25P/E 12.7-25%Mixed on our tests (recalculated)
2026-07-27P/E 12.7-25%Mixed on our tests (recalculated)
2026-07-31P/E 14.6-13%Mixed on our tests (recalculated)
2026-08-03P/E 14.2-16%Mixed on our tests
2026-08-07P/E 14.7-13%Mixed on our tests (recalculated)
2026-08-10P/E 15.0-11%Mixed on our tests
2026-08-14P/E 15.4-9%Mixed on our tests (recalculated)
2026-08-17P/E 15.4-9%Mixed on our tests
2026-08-21P/E 15.4-9%Mixed on our tests (recalculated)
2026-08-24P/E 15.6-8%Mixed on our tests
2026-08-27P/E 15.6-8%Mixed on our tests (recalculated)
2026-08-28P/E 15.1-11%Mixed on our tests (recalculated)
2026-08-30P/E 14.9-12%Mixed on our tests (recalculated)
2026-08-31P/E 14.9-12%Mixed on our tests
2026-09-05P/E 14.3-15%Mixed on our tests (recalculated)
2026-09-07P/E 14.3-15%Mixed on our tests
2026-09-12P/E 13.2-22%Mixed on our tests (recalculated)
2026-09-14P/E 13.2-22%Mixed on our tests
2026-09-19P/E 13.3-21%Mixed on our tests (recalculated)
2026-09-21P/E 13.3-21%Mixed on our tests
2026-09-26P/E 13.8-18%Mixed on our tests (recalculated)
2026-09-28P/E 13.8-18%Mixed on our tests
2026-10-03P/E 13.3-21%Favorable on our tests (recalculated)
2026-10-05P/E 13.3-21%Favorable on our tests ← now

Frequently asked questions

Is GE HealthCare Technologies stock overvalued?

At a blended P/E of 13.3 versus its historical normal P/E of 16.9, GE HealthCare Technologies trades about 21% below its typical valuation, with a PEG of 1.28 on 10.4% forward growth. tickerseer currently rates it favorable on our tests.

What is GE HealthCare Technologies's fair value and PEG?

GE HealthCare Technologies trades at a blended P/E of 13.3 against a historical normal P/E of 16.9, a PEG of 1.28, and a forward growth estimate of 10.4%. Priced at its historical normal P/E of 16.9 on the same blended earnings, the 2026-10-02 close of $64.29 corresponds to about $81.80 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of GE HealthCare Technologies changed?

tickerseer's rating moved from mixed on our tests (2026-06-10) to favorable on our tests (2026-10-05).

What is the analyst price target for GE HealthCare Technologies?

The mean Wall Street price target for GE HealthCare Technologies is $83.05 across 19 analysts, 29.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Equipment. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track GEHC free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.